Media

mar 18, 2021

Why we should take a second look at RNA technology,  an article by Gabriele Campi published in the March 2021 edition of MedNous, a publication of Evernow Publishing Ltd.

feb 09, 2021

Funding for microRNA company, MedNous

feb 09, 2021

InteRNA Technologies Extends Series B Financing Round Totaling EUR 18.5M, FinanzNachrichten.de

feb 09, 2021

InteRNA Technologies Extends Series B Financing Round Totaling EUR 18.5M, Yahoo! Finance

feb 09, 2021

Interna closes $22M series B round as it enters the clinic, BioWorld

feb 09, 2021

InteRNA Technologies Extends Series B Financing Round Totaling EUR 18.5M, Wfmj.com

feb 09, 2021

InteRNA Technologies Extends Series B Financing Round Totaling €18.5M, Finsmes.com

feb 09, 2021

InteRNA Technologies secures €18.5m in Series B financing, European Biotechnology

feb 09, 2021

InteRNA Technologies Extends Series B Financing Round Totaling EUR 18.5M, BusinessWire

dec 15, 2020

Financings for Dec. 15, 2020, Bioworld

feb 18, 2020

Aurora Science raises investment finance for early stage projects, Bioworld

feb 14, 2020

Italian Investment Firm AurorA Science Launches to Support Early Stage Biotechs, Labiotech.eu

feb 12, 2020

AurorA debuts to back early-stage European biotechs, BioCentury.com

feb 10, 2021

Secondo investimento di Aurora Science, i vantaggi dell’innovazione con le aziende, EconomyUp

feb 10, 2021

Aurora Science chiude il suo secondo investimento nelle biotecnologie, StartupBusiness

feb 10, 2021

Aurora Science investe 18,5 milioni in terapie Rna oncologiche, MilanoFinanza

feb 10, 2021

Secondo investimento per Aurora Science, che partecipa al round di InteRNA Technologies, BeBeez

dec 16, 2020

Peptomyc cierra una ronda de 11,4 millones para realizar un ensayo clínico contra el cáncer, Planta Doce

dec 16, 2020

Round da 11,4 mln euro per la biotech spagnola Peptomyc. Lo guida AurorA Science, BeBeez

dec 15, 2020

Biotech, Aurora Science guida un round di investimento da 11,4 milioni in Peptomyc, About Pharma

feb 14, 2020

Nasce AurorA Science, la società di investimento in startup Biotech, StartupItalia

feb 12, 2020

Aurora-TT, Rottapharm e Italfarmaco insieme per investire in biotech, StartupBusiness

feb 12, 2020

Nasce AurorA-Science, società di investimento in startup biotech, AboutPharma

feb 12, 2020

Rottapharm Biotech e Italfarmaco lanciano AurorA Science per investire in startup biotech con un team di manager del settore, BeBeez.it

feb 12, 2020

AurorA Science, due aziende pharma si alleano per investire su startup biotech, EconomyUp

feb 09, 2021

AurorA Science leads the investment in InteRNA Technologies B.V. and continues its portfolio growth

dec 17, 2020

AurorA Science announces the start of biotech investment activities with a transaction to support Peptomyc, S.L.

feb 12, 2020

Rottapharm Biotech and Italfarmaco team up with AurorA-TT to launch AurorA Science, a Biotech Investment Company integrating an Innovative Financial and Industrial Approach in the Research and Development Challenge.

dic 17, 2020

AurorA Science annuncia l’inizio delle attività di investimenti biotech con una transazione a supporto di Peptomyc

feb 12, 2020

Rottapharm Biotech e Italfarmaco si alleano con AurorA-tt e lanciano Aurora Science, società di investimento in start-up biotech che integra finanza e industria.